Laboratory Investigation Report Summary

Laboratory Investigation Report
Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Age/Gender : 93 Y 0 M 1 D /M OP/IP No : OP//MAXHOME
Max ID/Mobile : SHPS.150531/9810177171 Collection Date/Time : 21/Aug/2022 10:25AM
Lab ID : 1322082202479 Receiving Date : 21/Aug/2022
Ref Doctor : Dr.Krishnendu Kumar Nayak Reporting Date : 21/Aug/2022
Passport No. :
Hematology
WellWise Exclusive Profile- Male
Complete Haemogram, Peripheral Smear and ESR,EDTA

Date 21/Aug/2022 Unit Bio Ref
10:25AM Interval
Haemoglobin 12.1 g/dl 13.0 - 17.0
Modified cyanmethemoglobin
Packed Cell, Volume 38.1 % 40-50
Calculated
Total Leucocyte Count 10.3 10~9/L 4.0-10.0
(TLC)
Electrical Impedance
RBC Count 4.27 10~12/L 4.5-5.5
MCV 89.2 fL 83-101
MCH 28.3 pg 27-32
Calculated
MCHC 31.7 g/dl 31.5-34.5
Calculated
Platelet Count 107 10~9/L 150-410
MPV 12.7 fl 7.8-11.2
Calculated
RDW 16.3 % 11.5-14.5
Calculated
Differential Cell Count

VCS / Light Microscopy
Neutrophils 90.6 % 40-80

Lymphocytes 1.7 % 20-40
Monocytes 7.2 % 2-10
Eosinophils 0.4 % 1-6
Basophils 0.1 % 0-2
Absolute Leukocyte Count

Calculated from TLC & DLC
Absolute Neutrophil Count 9.33 10~9/L 2.0-7.0

Absolute Lymphocyte 0.2 10~9/L 1.0-3.0
Page 1 of 17
SIN No:B2C075235, Test Performed at :585 - Max Hospital - Gurugram, Opposite HUDA City Centre Metro Station, B - Block
Booking Centre :1590 - MAX@Home, 21, 0000000000
The authenticity of the report can be verified by scanning the Q R Code on top of the page

Passport No. :
Hematology
Count
Absolute Monocyte Count 0.74 10~9/L 0.2-1.0
Absolute Eosinophil Count 0.04 10~9/L 0.02-0.5
Absolute Basophil Count 0.01 10~9/L 0.02-0.1
ESR (Westergren) 38 mm/hr <=30
Peripheral Smear
Examination
RBC: - Anisocytosis (+) , Predominantly Normocytic Normochromic
WBC: - Mild leukocytosis with neutrophilia
Platelet: - Thrombocytopenia
Kindly correlate with clinical findings
*** End Of Report ***
Page 2 of 17

Passport No. :
Clinical Biochemistry
Fasting Blood Sugar (Glucose) , (FBS), Fluoride Plasma

Date 21/Aug/2022 Unit Bio Ref Interval
10:25AM
Glucose (Fasting) 266 mg/dL 74 - 99
Hexokinase
Page 3 of 17

Passport No. :
HbA1c (Glycated/ Glycosylated Hemoglobin) Test*

HPLC

10:25AM Interval
Glycosylated 8.1 % < 5.7
Haemoglobin(Hb A1c)
Glycosylated 65.02 mmol/mol < 39.0
Haemoglobin(Hb A1c)
IFCC
Average Glucose Value 185.77 mg/dL
For the Last 3 Months
Average Glucose Value 10.29 mmol/L
For the Last 3 Months
IFCC
Interpretation The following HbA1c ranges recommended by the American Diabetes Assocation(ADA) may be used as an aid in the diagnosis of diabetes
mellitus.
HbA1C(NGSP %) HbA1C(IFCC mmol/mol) Suggested Diagnosis

> 6.5 > 48 Diabetic
5.7 - 6.4 39 - 47 Pre- Diabetic
< 5.7 < 39 Non - Diabetic
HbA1C provides a useful index of average glycaemia over the preceding 6-8 weeks.
It is suggested that HbA1c is measured every 6 months in stable patients, every 3 months in patients with unstable metabolic control and every month in
pregnancy.
Increased Glycated hemoglobin is a reflection of Hyperglycemia.
Page 4 of 17

Passport No. :
Page 5 of 17

Passport No. :
Immunoassay
Thyroid Profile*,Serum
10:25AM Interval
Free Triiodothyronine 2.70 pg/mL 2.6 - 4.2
(FT3)
CLIA
Free Thyroxine (FT4) 0.86 ng/dL 0.58 - 1.64
CLIA
Thyroid Stimulating 10.59 µIU/mL 0.34 - 5.6
Hormone
CLIA
Comment
Premature Cord Blood
Upto 2 1st 2nd 3rd
Parameter Unit (28 - 36 (> 37 Adult
Month Trimester Trimester Trimester
weeks) weeks)
FT3 Pg/mL 0.15 - 3.91 2.4 - 5.6 2.6 - 4.2 2.11 - 3.83 1.96 - 3.38 1.96 - 3.38
TSH uIU/ml 0.7 - 27.0 2.3 - 13.2 0.5 - 10 0.38 - 5.33 0.1 - 2.5 0.2 - 3.0 0.3 - 3.0
Note : TSH levels are subject to circadian variation, reaching peak levels between 2 – 4 am
and at a minimum between 6 – 10 pm. The variation is of the order of 50% - 206 %, hence
time of the day has influence on the measured serum TSH concentrations.
Page 6 of 17

Passport No. :
Immunoassay
Page 7 of 17

Passport No. :
Kidney Function Test (KFT) Profile with Calcium, Uric Acid, Serum
10:25AM Interval
Urea 33.0 mg/dL 17.0 - 43.0
Urease, UV
Blood Urea Nitrogen 15.42 mg/dL 7.9 - 20.0
Calculated
Creatinine 0.67 mg/dL 0.9 - 1.3
Alkaline picrate kinetic
eGFR 110.70 ml/min/1.73
MDRD m²
Bun/Creatinine Ratio 23.01 Ratio 12:1 - 20:1
Calculated
Uric Acid 3.3 mg/dL 3.5 - 7.2
Uricase, Colorimetric
Calcium (Total) 8.65 mg/dL 8.8 - 10.6
Arsenazo III
Sodium 138.2 mmol/L 136 - 146
ISE indirect
Potassium 3.6 mmol/L 3.5 - 5.1
ISE indirect
Chloride 101.7 mmol/L 101 - 109
ISE indirect
Bicarbonate 27.0 mmol/L 21 - 31
Enzymatic
Interpretation Ref. Range

eGFR - Estimated Glomerular Filteration Rate is calculated by MDRD equation which is most accurate for GFRs ≤ 60ml / min /1.73 m².MDRD equation is used
for adult population only.
<60ml / min / 1.73 m² - Chronic Kidney Disease
<15 ml / min /1.73 m² - Kidney failure
BUN/Creatinine Ratio :-
Increased in reduced renal perfusion (e.g. dehydration, Hypovolemic shock, Congestive Heart Failure) or Obstructive uropathy. Decreased in Acute Renal Tubular
necrosis.
Page 8 of 17

Passport No. :
Page 9 of 17

Passport No. :
Liver Function Test (LFT), Serum

10:25AM
Total Protein 6.79 g/dL 6.6 - 8.3
Biuret
Albumin 4.0 g/dL 3.5 - 5.2
Bromcresol Green (BCG)
Globulin 2.8 g/dl 2.3 - 3.5
Calculated
A.G. ratio 1.5 1.2 - 1.5
Calculated
Bilirubin (Total) 1.28 mg/dL 0.3 - 1.2
DPD
Bilirubin (Direct) 0.36 mg/dL 0.0 - 0.2
Diazotization
Bilirubin (Indirect) 0.92 mg/dL 0.1 - 1.0
Calculated
SGOT- Aspartate 25 U/L < 50
Transaminase (AST)
UV without P5P
SGPT- Alanine 13 U/L < 50
Transaminase (ALT)
UV without P5P
AST/ALT Ratio 1.92 Ratio
Calculated
Alkaline Phosphatase 142 U/L 30 - 120
PNPP, AMP Buffer
GGTP (Gamma GT), 16.0 U/L < 55
Serum
Enzymatic Rate
Interpretation AST/ALT Ratio : -

In Case of deranged AST and/or ALT, the AST/ALT ratio is < 2.0 in alcoholic liver damage and > 2.0 in non – alcoholic liver damage
Page 10 of 17

Passport No. :
Lipid Profile,Serum
10:25AM Interval
Cholesterol 168 mg/dL < 200
Cholesterol oxidase, esterase,
peroxidase
HDL Cholesterol 48.0 mg/dL > 40
Direct measure, immunoinhibition
LDL Cholesterol 115.0 mg/dL < 100
Direct measure
Triglyceride 76.0 mg/dL < 150
Enzymatic, end point
VLDL Cholesterol 15.2 mg/dl < 30
Calculated
Total Cholesterol/HDL 3.5 .. 0.0-4.9
Ratio
Calculated
Non-HDL Cholesterol 120.00 mg/dL < 130
Calculated
HDL/LDL 0.42 Ratio 0.3 - 0.4
Calculated
Interpretation
Optimal: < 100 mg/dL

Near Optimal/ Above Optimal: 100-
Desirable: < 200 mg/dL
129
Borderline High: 200-239
Total mg/dL
mg/dL LDL-C
Cholesterol Borderline High: 130-159 mg/dL
High ≥ 240 mg/dL
High: 160-189 mg/dL
Very High: ≥ 190 mg/dL
Normal: <150 mg/dL

Low HDL: < 40 mg/dL Borderline High: 150-199 mg/dL
HDL-C Triglyceride
High HDL: ≥ 60 mg/dL High: 200-499 mg/dL
Very High: ≥ 500 mg/dL
Page 11 of 17

Passport No. :
CRP (C-Reactive Protein), High Sensitive, Serum

10:25AM Interval
C-Reactive Protein, High 0.69 mg/dL
Sensitive
Latex particle
Immunoturbidimetric
Reference Values in the table given below are recommended cardiovascular risk groups, in primary prevention settings by AHA/CDC and NACB expert panel.
Risk Level CRP (mg/L) CRP (mg/dL)

Low < 1.0 < 0.10
Average 1.0 - 3.0 0.10 - 0.30
>0.30
High > 3.0
Increase in CRP levels is non – specific, and interpretation must be undertaken in comparison with previous Hs CRP values or other cardiac risk indicators
(Cholesterol, HDL etc.) Single measurement may lead to an erroneous assessment of early cardiac inflammation.
Page 12 of 17

Passport No. :
Inorganic Phosphorus, Serum

10:25AM Interval
Phosphorus(inorg) 2.89 mg/dL 2.5 - 4.5
Phosphomolybdate-UV
Interpretation
Increased in Osteolytic metastatic bone tumors, myelogenous leukemia, sarcoidosis, milk-alkali syndrome, vitamin D intoxcation, healing fractures, renal failure,
hyperparathyroidism, PTH resistance (Pseudohypoparathyroidism) and diabetes mellitus with ketosis.
Decreased in Osteomalacia, steatorrhea, renal tubular acidosis, growth hormone deficiency, acute alcoholism, gram-negative bacterial septicemia, hypokalemia,
familial hypophosphatemic rickets, Vitamin D deficiency, severe malnutrition, malabsorption, secondary diarrhea, vomiting, nasogastric suction, primary
hyperthyroidism and PTH producing tumors.
Total Iron Binding Capacity (TIBC), Serum

10:25AM
Iron 49.7 μg/dL 70 - 180
TPTZ- No deproteinization
UIBC 303 μg/dL 155 - 355
Nitroso - PSAP
Total Iron Binding 352.7 μg/dL 225 - 535
Capacity
Calculated
Transferrin Saturation 14.09 % 17 - 37
Calculated
Page 13 of 17

Passport No. :
Page 14 of 17

Passport No. :
Immunoassay
Ferritin, Serum
10:25AM
Ferritin 67.5 ng/mL 23.9 - 336.2
CLIA
Comment Ferritin is a large hollow spherical protein containing iron, concentration of which roughly reflects the body iron content in many individuals. Serum
ferritin concentration is a sensitive indicator of iron deficiency. Serum Ferritin concentration is increased in many disorders like infection, inflammatory disorders
like rheumatoid arthritis or renal disease; common liver conditions (e.g. alcoholism, viral hepatitis B or C); heart disease, cancer. In patients with these disorders
who also have iron deficiency their serum ferritin concentrations are often normal. An increase in serum ferritin concentration occurs as a result of ferritin release
due to liver cell injury of diverse causes. Serum ferritin is also increased in patients with iron overload of any cause. Serum transferrin saturation is a better
screening test for early iron overload than serum ferritin.
Page 15 of 17

Passport No. :
Immunoassay
Vitamin D, 25 - Hydroxy Test (Vit. D3), Serum

10:25AM Interval
25 Hydroxy, Vitamin D 4.01 ng/mL 30-100
CLIA
Ref Range
25 (OH) Vitamin D Concentration Range
Vitamin D Status
(ng/ml)
Sufficiency 30-100
Insufficiency 20-29
Deficiency <20
Potential Toxicity
>100
Interpretation
Vitamin D toxicity can be due to
1. Use of high doses of vitamin D for prophylaxis or treatment
2. Taking vitamin D supplements with existing health problems such as kidney disease, liver disease , tuberculosis and hyperparathyroidism
Vitamin D deficiency can be due to:
1. Inadequate exposure to sunlight,
2. Diet deficient in vitamin D
3. Malabsorption
Advice: Serum calcium, phosphorus and PTH
Prostate Specific Antigen (P.S.A.) - Total, Serum

10:25AM
Prostate Specific Antigen 0.52 ng/mL <4.00
CLIA
Page 16 of 17

Passport No. :
Immunoassay
Vitamin B12 (Vit- B12), (Cyanocobalamin), Serum

10:25AM
Vitamin B12 99.0 pg/mL 120 - 914
CLIA
Interpretation
Note:- Vitamin B12 (Cobalamin)
Vitamin B12 is tested for patients with GIT disease, Neurological disease, psychiatric disturbances, malnutrition, alcohol abuse.
Increased in chronic renal failure, severe CHF.
Decreased in megaloblastic anemia.
Advise: CBC, peripheral smear, serum folate levels, intrinsic factor antibodies (IFA), bone marrow examination, if Vit B12 deficient.

Results to follow:
Urine Routine And Microscopy : Sample not yet received
Page 17 of 17

Laboratory Investigation Report Summary

Uploaded by

Document Information

Original Title

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Laboratory Investigation Report Summary

Uploaded by

Copyright:

Available Formats

Laboratory Investigation Report

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Complete Haemogram, Peripheral Smear and ESR,EDTA

Differential Cell Count

Neutrophils 90.6 % 40-80

Absolute Leukocyte Count

Absolute Neutrophil Count 9.33 10~9/L 2.0-7.0

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Kindly correlate with clinical findings

*** End Of Report ***

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Fasting Blood Sugar (Glucose) , (FBS), Fluoride Plasma

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

HbA1c (Glycated/ Glycosylated Hemoglobin) Test*

Date 21/Aug/2022 Unit Bio Ref

HbA1C(NGSP %) HbA1C(IFCC mmol/mol) Suggested Diagnosis

Kindly correlate with clinical findings

*** End Of Report ***

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Kindly correlate with clinical findings

*** End Of Report ***

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Interpretation Ref. Range

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Liver Function Test (LFT), Serum

Interpretation AST/ALT Ratio : -

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Optimal: < 100 mg/dL

Normal: <150 mg/dL

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

CRP (C-Reactive Protein), High Sensitive, Serum

Risk Level CRP (mg/L) CRP (mg/dL)

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Inorganic Phosphorus, Serum

Total Iron Binding Capacity (TIBC), Serum

Kindly correlate with clinical findings

*** End Of Report ***

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Vitamin D, 25 - Hydroxy Test (Vit. D3), Serum

Prostate Specific Antigen (P.S.A.) - Total, Serum

Patient Name : Mr. Dn Raina Centre : 1590 - Max@Home

Vitamin B12 (Vit- B12), (Cyanocobalamin), Serum

Kindly correlate with clinical findings

You might also like

* End Of Report *

* End Of Report *

* End Of Report *

* End Of Report *